| Name | Title | Contact Details |
|---|
BayCare Clinic is a physician-owned specialty care clinic based in Green Bay, Wisconsin, that offers expertise in more than 20 specialties with over 100 physicians serving in 16 area communities. BayCare Clinic is a joint partner in Aurora BayCare Medi...
Sports Facility | Whitesboro, NY
Heyday is a people-first skincare company, bringing together human touch, expertise, and data to personalize and empower people to take care of their skin. We opened our first retail location in 2015 – taking the facial and indulgence out of the spa, elevating the estheticians as the experts they are, and removing the overwhelm out of building an at-home skincare routine. Today, we have 9 locations in New York, Los Angeles, and Philadelphia. We`ve performed 225,000 facials, collected data on skincare conditions, preferences, and purchases, and become an employer of choice for a world-class team of estheticians we call Heyday Skin Therapists. Our next chapter is to take these ingredients and create unparalleled personalization and guidance across content, communities, recommendations, and services in both our physical stores and our e-commerce experience. `Heyday` means a period of your life when you`re feeling at your best. Above all, we exist to help people achieve their `heyday` – to show up in the world as their best selves, every day. We start with the skin you`re in.
pSivida is a leading provider of miniaturized, sustained-release drug delivery products and is continuing the evolution of these systems.
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.